Evaluation of a Common Variant of the Gene Encoding Clara Cell 10 kd Protein (CC10) as a Candidate Determinant for Asthma Severity and Steroid Responsiveness Among Chinese Children
- 13 July 2012
- journal article
- research article
- Published by Taylor & Francis in Journal of Asthma
- Vol. 49 (7) , 665-672
Abstract
Objective. The gene (SCGB1A1) encoding Clara cell 10-kDa protein (CC10), a steroid-inducible immune modulator, is a candidate gene for asthma, but the evidence is equivocal. The potential influence of a common variant on asthma severity and serum CC10 levels during acute exacerbation and after corticosteroid treatment in Chinese case–control children and its functional relevance was investigated. Methods. Genotyping of a non-coding variant G+38A was performed in 489 children, of whom 277 had asthma with varying severity, and 212 healthy controls. Associations were tested for asthma, asthma severity, and responsiveness to steroid treatment. The transcriptional activity of this variant was examined in a Clara-like cell line (H358) using transient transfection assays. Results. Significant association was observed for the combined GA and AA genotypes of the CC10 G+38A variant and an increased risk of asthma [odds ratio (OR), 2.62, p < .001]. This association was correlated with asthma severity (moderate: OR, 2.85, p < .001; near-fatal: OR, 4.81, p < .001). Also, patients with the GA and AA genotypes showed significantly lower serum CC10 (p < .01) and provocation concentration causing a 20% fall (PC20) in forced expiratory volume in 1 s (FEV1) (p < .0001) when compared with those with the GG. After glucocorticoid treatment, the CC10 levels were significantly increased in asthmatic patients with GG (p < .0001), but not those with the GA and AA genotypes. Moreover, a lower dexamethasone-induced reporter (luciferase) activity was observed for H358 cells transiently transfected with the G38A risk allele (A) compared with wild-type allele (G). Conclusions. These findings suggest that the CC10 G+38A variant may contribute to the severity of asthma and lower level of steroid responsiveness.Keywords
This publication has 41 references indexed in Scilit:
- Clara Cells Attenuate the Inflammatory Response through Regulation of Macrophage BehaviorAmerican Journal of Respiratory Cell and Molecular Biology, 2010
- Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC)Thorax, 2007
- Suppression of lipopolysaccharide- and tumour necrosis factor-α-induced interleukin (IL)-8 expression by glucocorticoids involves changes in IL-8 promoter acetylationClinical and Experimental Immunology, 2007
- Inverse relation between nasal fluid Clara Cell Protein 16 levels and symptoms and signs of rhinitis in allergen‐challenged patients with intermittent allergic rhinitisAllergy, 2007
- A critical review of the use of Clara cell secretory protein (CC16) as a biomarker of acute or chronic pulmonary effectsBiomarkers, 2007
- Prevalence and severity of symptoms of asthma, rhinitis, and eczema in 13- to 14-year-old children in Taipei, TaiwanAnnals of Allergy, Asthma & Immunology, 2005
- Association of an intragenic microsatellite marker in the CC16 gene with asthma in the Indian populationJournal of Human Genetics, 2004
- Clara cell secretory protein: determination of serum levels by an enzyme immunoassay and its importance as an indicator of bronchial asthma in childrenJournal of Pharmaceutical and Biomedical Analysis, 2004
- Glucocorticoids regulate the CCSP and CYP2B1 promoters via C/EBPβ and δ in lung cellsBiochemical and Biophysical Research Communications, 2002
- Protein content in bronchoalveolar lavage fluid of patients with asthma and control subjectsJournal of Allergy and Clinical Immunology, 1995